| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 22 |
| 1 | ASPIRIN | 18 |
| 2 | ASPIRIN 325 MG | 18 |
| 3 | ASPIRIN 81 MG | 18 |
| 4 | TACROLIMUS | 17 |
| 5 | ORAL SEMAGLUTIDE | 16 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 15 |
| 7 | TACROLIMUS OINTMENT 0.1% | 15 |
| 8 | METFORMIN | 12 |
| 9 | GEMCITABINE HYDROCHLORIDE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZOLBETUXIMAB | 2 | 0.0013 |
| 1 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 10 | 0.0012 |
| 2 | ESTRADIOL/NORETHINDRONE ACETATE | 2 | 0.0010 |
| 3 | AMPICILLIN | 6 | 0.0007 |
| 4 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 3 | 0.0007 |
| 5 | AMLODIPINE BESYLATE AND VALSARTAN | 6 | 0.0005 |
| 6 | DAPRODUSTAT | 1 | 0.0005 |
| 7 | AMPICILLIN INJECTION | 3 | 0.0004 |
| 8 | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | 1 | 0.0004 |
| 9 | DEUCRAVACITINIB | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 6 | 0.0016 |
| 1 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 2 | 0.0013 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |